ElectroCore Inc(ECOR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.7 | Insider Own | 32.89% | Shs Outstand | 9.0M | Perf Week | -3.76% |
| Market Cap | 0.06B | Forward P/E | - | EPS next Y | 54.76% | Insider Trans | -2.94% | Shs Float | 6.0M | Perf Month | -29.39% |
| Enterprise Value | 0.06B | PEG | - | EPS next Q | -0.27 | Inst Own | 13.67% | Short Float | 5.75% | Perf Quarter | 14.93% |
| Income | -0.01B | P/S | 1.75 | EPS this Y | 16.61% | Inst Trans | 11.54% | Short Ratio | 3.98 | Perf Half Y | 7.19% |
| Sales | 0.04B | P/B | - | EPS next 5Y | - | ROA | -93.41% | Short Interest | 0.35M | Perf YTD | 59.64% |
| Book/sh | -0.31 | P/C | 6.43 | EPS past 3/5Y | 29.44% 28.87% | ROE | -478.7% | 52W High | -43.62% ($12.70) | Perf Year | 42.06% |
| Cash/sh | 1.11 | P/FCF | - | Sales past 3/5Y | 55.06% 55.74% | ROIC | -274.03% | 52W Low | 62.36% ($4.41) | Perf 3Y | 12.76% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 0.24% | Gross Margin | 85.47% | Volatility(W/M) | 10.51% 8.69% | Perf 5Y | -50.41% |
| Dividend TTM | - | EV/Sales | 1.73 | Sales Y/Y TTM | 33.45% | Oper. Margin | -37.64% | ATR (14) | 0.73 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1 | EPS Q/Q | 26.3% | Profit Margin | -39.96% | RSI (14) | 34.63 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.21 | Sales Q/Q | 28.03% | SMA20 | -12.8% ($8.21) | Beta | 1.23 | Target Price | $19.17 |
| Payout | - | Debt/Eq | - | Earnings | 2026/11/4 | SMA50 | -24.05% ($9.43) | Rel Volume | 1.08 | Prev Close | $7.52 |
| Employees | 83 | LT Debt/Eq | - | EPS/Sales Surpr. | 21.76% -0.46% | SMA200 | -7.49% ($7.74) | Avg Volume(3M) | 0.09M | Price | $7.16 |
| IPO | 2018/6/22 | Option/Short | No/Yes | Trades | 643 | Volume | 94,139 | Change | -4.79% |
A medical device company specializing in non-invasive bioelectronic technology that stimulates the occipital nerve to treat migraines and cluster headaches.
Over the past 1 year, roughly in the middle
44% below its 1-year high.
Traded about as much as usual. That is 108% of its average volume.
Next earnings report: November 4
1 days to go.
ECOR has weak earning power
Of every $100 in sales, $37.64 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +16.6% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $175. Peers typically go for $145.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -50.4%. The S&P 500 did +63% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 13.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #92 of 140 in the industry
Based on market cap of $65M.
HYPR#88 Hyperfine Inc $77M PER - 
OM#89 Outset Medical Inc $75M PER - 
MBOT#90 Microbot Medical Inc $70M PER - 
LNSR#91 LENSAR Inc $70M PER - ECOR#92 ElectroCore Inc $65M PER - 
FAQ
What kind of company is ECOR?
ECOR belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of ECOR?
The market cap of ECOR is approximately $65M, ranking 4,716 within its sector.
What is the 52-week high and low for ECOR?
ECOR has recorded a 52-week high of $12.70 and a low of $4.41.
